Fatigue and symptom-based clusters in post COVID-19 patients: a multicenter, prospective, observational cohort study


Merel E. B. Cornelissen, Lizan D. Bloemsma, , et. al., Journal of Translational Medicine volume 22, Article number: 191 (2024) Abstract Background In the Netherlands, the prevalence of post COVID-19 condition is estimated at 12.7% at 90–150 days…[...]

Therapies for pain conditions like fibromyalgia provide clues for helping those with long COVID


Many patients continue to struggle in the wake of the pandemic as they grapple with ongoing symptoms triggered by COVID-19 infection, a condition commonly known as long COVID. However, the…[...]

COVID-19 symptom load as a risk factor for chronic pain: A national cross-sectional study


Jamie L. Romeiser , Sunitha M. Singh, et. al. https://doi.org/10.1371/ journal.pone.0287554 Abstract Introduction Emerging evidence suggests that a COVID-19 infection with a high initial severity may be associated with development of…[...]

Does nerve damage contribute to long COVID symptoms?


Almost all post-COVID neuropathy linked to a potentially treatable immune dysfunction MGH News and Public Affairs A new study suggests that some patients with long COVID have lasting nerve damage…[...]

Resonant breathing improves self-reported symptoms and wellbeing in people with Long COVID


Jessica Polizzi, Jenna Tosto-Mancuso, Laura Tabacof, Jamie Wood, David Putrino Cohen Center for Recovery from Complex Chronic Illnesses, Icahn School of Medicine at Mount Sinai, New York, NY, United States…[...]

New-onset chronic musculoskeletal pain following COVID-19 infection fulfil the Fibromyalgia clinical syndrome criteria


Omar Khoja,  Matthew Mulvey, Sarah Astill,  et. al. ,doi: https://doi.org/10.1101/2024.07.10.24310234 ABSTRACT Background New-onset chronic musculoskeletal (MSK) pain (> 3 months duration) is one of the commonest persistent symptoms of Post-COVID syndrome (PCS). There is emerging evidence that the…[...]

Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study.


O'Kelly B 1,2, Vidal L 2, McHugh T 2, et. al. Brain, Behavior, & Immunity - Health, 03 Jul 2022, 24:100485, https://doi.org/10.1016/j.bbih.2022.100485 PMID: 35814187 PMCID: PMC9250701 Abstract  Background Up to 37.7% of patients experience symptoms beyond 12 weeks after…[...]

Patients with neurological disease are likelier to die after COVID, finds study


by Geoff McMaster, University of Alberta People with neurological disease have a greater chance of death after contracting COVID-19, according to a new University of Alberta study. The research also confirms…[...]